Teleneuropsychological Intervention in Asymptomatic HIV Seropositive Patients: N&C NeuroChange
Key facts
- Who runs it
- Universidad Nacional Autonoma de Mexico
- Where
- Mexico1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- 16 May 2022
- Ended
- 30 May 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- Cognitive stimulation program
- Record updated
- 3 July 2024
- Why it stopped
- experimental abandonment
Who can take part
- Age
- 20 years to 45 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Male or females with HIV
- Minimum primary education
- From 20 to 45 years old
- Normal or corrected vision and hearing
- Treatment adherence
Who cannot take part
- Hormonal therapy
- Neurological and psychiatric history (except mood disorders)
- AIDS associated diseases
- Head injuries
- Cerebrovascular events
- Substance abuse
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Currently 37.9 million people are living with human immunodeficiency virus (HIV) around the world (UNAIDS, 2018). Even with antiretroviral treatment (ART), the virus enters the central nervous system and can affect the following structures: amygdala, hippocampus, thalamus, parietal, frontal, temporal regions, orbitofrontal, cingulate, motor and sensory cortex; generating cognitive, behavioral and motor alterations, up to HIV-associated neurocognitive disorder (HAND) and occasionally HIV-associated dementia (HAD).
Read full original descriptionShow less
Few clinical studies have been conducted using computerized cognitive rehabilitation programs to counteract neuropsychological alterations. The aim of this project is to explore the feasibility of a cognitive stimulation program (CSP) developed to strengthen cognitive domains identified as impaired through a neuropsychological assessment in asymptomatic HIV+ patients adherent to ART, with the purpose of improving their quality of life and mood disorder.
The 2 groups in the trial
- Study groupTreatment being tested
Refers to the experimental group that will receive the cognitive stimulation program intervention.
Treatment: Cognitive stimulation program
- Waiting list control groupOther group
Will be the control group that remains without intervention until the study group completes the cognitive stimulation program and the subsequent neuropsychological assessment has been done. Once the intervention is completed with the study group, the same program will be applied to the control group.
Treatment: Cognitive stimulation program
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Feasibility and Usefulness of a Neuropsychological Telerehabilitation Program in Asymptomatic HIV Patients: Pilot Randomized Controlled Trial
- Record updated
- 3 July 2024